CD4+CD25high Treg cells are potent inhibitors of anti-tumor immune responses and the depletion of Treg cells promotes the rejection of several transplantable murine tumor cell lines including melanoma, fibrosarcoma, leukaemia, and myeloma. This evidence concerns the gene CD4 and leukemia.